Reports

Skip to content

About Anthem
CRDMO Services
- Small Molecules
  - Discovery
  - Clinical & Commercial
- Large Molecules
  - Discovery & Pre-Clinical
  - Clinical & Commercial
Tech Platforms & Modalities
Specialty Ingredients
Infrastructure
Investors

Contact

Home
»
Reports

Annual Report
FY 2024-25

Annual Report
FY 2023-24

Annual Report
FY 2022-23

Careers
Contact
Terms
Privacy

Anthem Biosciences is a fully integrated Contract Research, Development and Manufacturing Organization (“CRDMO”) delivering small molecules, large molecules, peptides, lipids, oligos, high-potent APIs and ADC solutions for global pharmaceutical and biotechnology partners.

Company

Anthem Overview
Anthem Advantage
Our Journey
Our Partners
Leadership
Board of Directors
Team
Investors
Digital Transformation
ESG, Health & Safety

CRDMO Services

Large Molecules
Small Molecules
HPAPI
Peptides
Lipids
ADCs
Oligonucleotides
New Age Chemistry

Specialty Ingredients

Fermentation Products
Probiotics
Functional Enzymes
Peptides
Biosimilars
Nutritional Actives
Vitamin Analogues
APIs
Biotransformation Enzymes

Infrastructure

Unit I
Unit II
Unit III

Design & Developed by Umanshi.

Reports

Annual Report FY 2024-25

Annual Report FY 2023-24

Annual Report FY 2022-23

Annual Report
FY 2024-25

Annual Report
FY 2023-24

Annual Report
FY 2022-23